RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM)

Clinical trials for RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM) explained in plain language.

Never miss a new study

Get alerted when new RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM) trials appear

Sign up with your email to follow new studies for RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1

Thai doctors test 'Living Drug' to fight incurable blood cancer

Disease control Not yet recruiting

This is an early safety study for a personalized cell therapy in Thai patients with multiple myeloma that has returned or stopped responding to standard treatments. Doctors will collect a patient's own immune cells, genetically modify them in a lab to hunt cancer, and infuse them…

Matched conditions: RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM)

Phase: EARLY_PHASE1 • Sponsor: Chulalongkorn University • Aim: Disease control

Last updated Apr 02, 2026 05:42 UTC

RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM)

Get alerted when new RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM) trials appear

Thai doctors test 'Living Drug' to fight incurable blood cancer